Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
A double-blind, placebo-controlled study to assess the efficacy of adjunctive treatment with
LEV 3000mg/day in reducing myoclonic seizures in adolescents and adults suffering from
idiopathic generalised epilepsy and to evaluate the safety of LEV in the same population.